NEW YORK, March 31, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sarepta Therapeutics, Inc. ("Sarepta" or the "Company") (NASDAQ: SRPT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The...
Hence then, the article about investor alert pomerantz law firm investigates claims on behalf of investors of sarepta therapeutics inc srpt was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT )
Also on site :
- ‘The Debut’ Explodes at Telluride With Julianne Moore’s Gonzo, Career-Best Turn, Thanks to Bananas, Unlit Cigarettes and a Faux Musical
- ‘The Debut’ Features Seven Original Songs, All Written by Jesse Eisenberg, and One Is Getting an Oscar Push (Exclusive)
- Original ‘Practical Magic’ Star Alexandra Artrip Addresses ‘Negativity’ Over Recasting in Sequel: They ‘Did What They Thought Was Best to Be Successful’